Embryonic stem cell research : exploring the controversy : hearing before the Subcommittee on Science, Technology, and Space of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Eighth Congress, second session, September 29, 2004.
Stem cell and regenerative medicine research is a hot area of research which promises to change the face of medicine as it will be practiced in the years to come. Challenges in the 21st century to combat diseases such as cancer, Alzheimer and related diseases may well be addressed employing stem cell therapies and tissue regeneration. Frontiers in Stem Cell and Regenerative Medicine Research is essential reading for researchers seeking updates in stem cell therapeutics and regenerative medicine. The seventh volume of this series features reviews on roles of mesenchymal stem cells and biomaterials in in vivo cartilage regeneration, liver regeneration, cardiogenesis and magnetic nanoparticles for regenerative therapy.
This multi-disciplinary book presents the current state of stem cell science in society, twenty years on from the first cultivation of human embryonic stem cells and ten years after the invention of genetically altered human stem cells. The once specialist field has morphed into a billion-dollar global endeavor. An array of applications has developed in the context of a growing bioeconomy that is highly dependent on patient donations, consumers and industrial support. The landscape of promises, problems and practices now forms a flexible matrix of intersecting agencies. This volume engages with normative, conceptual and infrastructural issues of this matrix, combining perspectives from scientists, social scientists, philosophers and ethicists. Together the chapters give a comprehensive overview of the current condition of stem cell research and its ethical and societal issues. This topical up-to-date volume is a valuable resource for researchers in different fields with the empirical case studies adding to its accessibility as a textbook and for a wider audience.